drugset / Trial / NCT02510599
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of solithromycin on hepatic histology and biomarkers in patients with nonalcoholic steatohepatitis.
Timeline
- Start
- 2015-12
- Primary completion
- 2017-01-27
- Completion
- 2017-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solithromycin | Other / unclassified | 200 mg | Oral |